By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – DNA Electronics today announced a deal making its nucleic acid testing platform available to geneOnyx for cosmetic and skincare applications.

The commercial license and supply agreement provides geneOnyx access to DNA Electronics' Genalysis platform, which geneOnyx will use to analyze a person's genetic makeup to determine how that person will react to certain product ingredients.

Financial and other terms of the deal were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The World Health Organization calls for the public release of clinical trial results within a year of the completion of data collection.

In Science this week: measles virus nucleocapsid structure, and more.

African and US health officials work to establish an Africa-wide Centres for Disease Control and Prevention.

Nature has retracted a 2002 epigenetics paper for image manipulation.

Apr
29
Sponsored by
Covance

This online seminar will review case studies demonstrating the clinical utility of CTCs and cfDNA to define and characterize a variety of dynamic genomic changes throughout the course of cancer detection and treatment.